##DESCRIPTION=tumor_af=Mutant allele frequency in tumor (Sample Tumor).
##DESCRIPTION=tumor_dp=Tumor Depth (Sample Tumor).
##DESCRIPTION=filter=Filter criteria from vcf file.
##DESCRIPTION=snp_q=Quality parameters - SNP quality (QUAL).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=interpro=Interpro domains.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD database.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=MetaLR=MetaLR effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen2=Polyphen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=FATHMM=FATHMM effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 15-20.
##DESCRIPTION=ihdb_hom=Homozygous variant counts in NGSD for the same processing system.
##DESCRIPTION=ihdb_het=Heterozyous variant counts in NGSD for the same processing system.
##DESCRIPTION=ihdb_wt=Wildtype variant counts in NGSD for the same processing system.
##DESCRIPTION=ihdb_allsys_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=ihdb_allsys_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validated=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Comments from the NGSD. Comments of other samples are listed in brackets!
##DESCRIPTION=gene_info=General gene information from the NGSD.
##DESCRIPTION=som_ihdb_c=Somatic variant count within NGSD.
##DESCRIPTION=som_ihdb_p=Projects with somatic variant in NGSD.
##FILTER=NOCALL=Generic filter. Filtering details stored in FR info tag.
##FILTER=not-cod-spli=Not a coding or splicing variant (filter_vcf).
##FILTER=syn-var=Synonymous variant (filter_vcf).

##ANALYSISTYPE=SOMATIC_SINGLESAMPLE
#chr	start	end	ref	obs	tumor_af	tumor_dp	filter	snp_q	gene	variant_type	coding_and_splicing	interpro	RepeatMasker	dbSNP	1000g	ExAC	gnomAD	COSMIC	OMIM	ClinVar	HGMD	phyloP	MetaLR	Sift	PolyPhen2	FATHMM	CADD	ihdb_hom	ihdb_het	ihdb_wt	ihdb_allsys_hom	ihdb_allsys_het	classification	classification_comment	validated	comment	gene_info	som_ihdb_c	som_ihdb_p
chr1	162741794	162741794	C	T	0.2328	16143	not-cod-spli	5240.33	DDR2	intron_variant	DDR2:NM_001014796.1:intron_variant:MODIFIER:exon13/18:c.1505-20C>T:,DDR2:NM_006182.2:intron_variant:MODIFIER:exon12/17:c.1505-20C>T:			rs3738807	0.104832	0.13380	0.09338		191311 [DDR2 (provisional) Spondylometaepiphyseal dysplasia,short limb-hand type,271665];	RCV000249018.1 [benign]; 																			
chr3	138665038	138665038	C	T	0.0533	75		11.0941	FOXL2	missense_variant	FOXL2:NM_023067.3:missense_variant:MODERATE:exon1/1:c.527G>A:p.Cys176Tyr				0.0000	0.0000	0.00000		605597 [FOXL2 (confirmed) Blepharophimosis,epicanthus inversus,and ptosis,type 1,110100|Blepharophimosis,epicanthus inversus,and ptosis,type 2,110100|Premature ovarian failure 3,608996];			0.000000	D	D,D	B	D	17.09												
chr3	138665122	138665122	C	T	0.0506	79		10.2346	FOXL2	missense_variant	FOXL2:NM_023067.3:missense_variant:MODERATE:exon1/1:c.443G>A:p.Arg148His	Winged_helix-turn-helix_transcription_repressor_DNA-binding__1_,Transcription_factor__fork_head__2_			0.0000	0.0000	0.0000		605597 [FOXL2 (confirmed) Blepharophimosis,epicanthus inversus,and ptosis,type 1,110100|Blepharophimosis,epicanthus inversus,and ptosis,type 2,110100|Premature ovarian failure 3,608996];			6.940000	D	D,D	D	D	34.00												
chr3	178936082	178936082	G	A	0.4876	4796		21314.4	PIK3CA	missense_variant	PIK3CA:NM_006218.3:missense_variant:MODERATE:exon10/21:c.1624G>A:p.Glu542Lys	Phosphoinositide_3-kinase__accessory__PIK__domain__3_,Armadillo-type_fold__1_,Phosphoinositide_3-kinase__accessory__PIK__domain__3_,Armadillo-type_fold__1_		COSM760;COSM17442;rs121913273	0.0000	0.0000	0.0000	COSM125369, COSM760	171834 [PIK3CA (provisional) Ovarian cancer,somatic,167000|Breast cancer,somatic,114480|Colorectal cancer,somatic,114500|Gastric cancer,somatic,613659|Hepatocellular carcinoma,somatic,114550|Nonsmall cell lung cancer,somatic,211980|Keratosis,seborrheic,somatic,182000|Nevus,epidermal,somatic,162900|CLOVE syndrome,somatic,612918|Megalencephaly-capillary malformation-polymicrogyria syndrome,somatic,602501|Cowden syndrome 5,615108];	RCV000024622.6 [pathogenic]; RCV000151649.1 [pathogenic]; RCV000154513.1 [pathogenic]; 	CM153078 [CLASS=DM MUT=ALT PHEN="Hemimegalencephaly" GENE=PIK3CA]; 	9.476000,9.476000	T,T	D,T	D,D	T,T	27.30												
chr4	1807894	1807894	G	A	1.0000	4448	syn-var	60686.2	FGFR3	synonymous_variant	FGFR3:NM_001163213.1:synonymous_variant:LOW:exon14/18:c.1959G>A:p.Thr653Thr,FGFR3:NM_000142.4:synonymous_variant:LOW:exon14/18:c.1953G>A:p.Thr651Thr,FGFR3:NM_022965.3:synonymous_variant:LOW:exon12/16:c.1617G>A:p.Thr539Thr			rs7688609	0.95607	0.98731	0.99005		134934 [FGFR3 (confirmed) Achondroplasia,100800|Hypochondroplasia,146000|Thanatophoric dysplasia,type I,187600|Crouzon syndrome with acanthosis nigricans,612247|Muenke syndrome,602849|Bladder cancer,somatic,109800|Colorectal cancer,somatic,114500|Cervical cancer,somatic,603956|LADD syndrome,149730|CATSHL syndrome,610474|Nevus,epidermal,somatic,162900|Thanatophoric dysplasia,type II,187601|Spermatocytic seminoma,somatic,273300|SADDAN,616482];																				
chr4	55141055	55141055	A	G	1.0000	4684	syn-var	61034.8	PDGFRA	synonymous_variant	PDGFRA:NM_006206.4:synonymous_variant:LOW:exon12/23:c.1701A>G:p.Pro567Pro			rs1873778	0.957668	0.98804	0.99028	COSM1430082	173490 [PDGFRA (confirmed) Gastrointestinal stromal tumor,somatic,606764|Hypereosinophilic syndrome,idiopathic,resistant to imatinib,607685];	RCV000250036.1 [benign]; RCV000281727.1 [benign]; RCV000385643.1 [benign]; 																			
chr4	55599436	55599436	T	C	0.5202	941	not-cod-spli	4735.12	KIT	intron_variant	KIT:NM_000222.2:intron_variant:MODIFIER:exon17/20:c.2484+78T>C:,KIT:NM_001093772.1:intron_variant:MODIFIER:exon17/20:c.2472+78T>C:			rs1008658	0.504792	0.0000	0.0000		164920 [KIT (confirmed) Piebaldism,172800|Gastrointestinal stromal tumor,familial,606764|Mast cell disease,154800|Leukemia,acute myeloid,601626|Germ cell tumors,273300];																				
chr7	55249063	55249063	G	A	1.0000	9457	syn-var	60433.0	EGFR,EGFR-AS1	synonymous_variant,non_coding_transcript_exon_variant	EGFR:NM_005228.3:synonymous_variant:LOW:exon20/28:c.2361G>A:p.Gln787Gln,EGFR-AS1:NR_047551.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.1201C>T:			rs1050171	0.432708	0.52278	0.52400	COSM1451600	131550 [EGFR (confirmed) Nonsmall cell lung cancer,response to tyrosine kinase inhibitor in,211980|Adenocarcinoma of lung,response to tyrosine kinase inhibitor in,211980|Nonsmall cell lung cancer,susceptibility to,211980|Inflammatory skin and bowel disease,neonatal,2,616069];	RCV000038427.3 [benign]; RCV000321080.1 [likely benign]; 	CM067987 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=EGFR]; 																		
chr7	140453136	140453137	AC	TT	0.9987	5162		65405.1	BRAF	missense_variant	BRAF:NM_004333.4:missense_variant:MODERATE:exon15/18:c.1798_1799delGTinsAA:p.Val600Lys	Serine-threonine/tyrosine-protein_kinase__1_,Protein_kinase-like_domain__1_,Protein_kinase__catalytic_domain__1_,,Serine-threonine/tyrosine-protein_kinase__1_,Protein_kinase-like_domain__1_,Protein_kinase__catalytic_domain__1_,,Serine-threonine/tyrosine-protein_kinase__1_,Protein_kinase-like_domain__1_,Protein_kinase__catalytic_domain__1_,		COSM6137;COSM18443;COSM476;COSM474;COSM249889;COSM473;rs113488022;rs121913227	0.0000	0.0000	0.0000	COSM6137	164757 [BRAF (confirmed) Melanoma,malignant,somatic|Colorectal cancer,somatic|Adenocarcinoma of lung,somatic,211980|Nonsmall cell lung cancer,somatic|Cardiofaciocutaneous syndrome,115150|Noonan syndrome 7,613706|LEOPARD syndrome 3,613707];	RCV000033335.2 [pathogenic]; RCV000208774.1 [pathogenic]; 	CM112509 [CLASS=DM MUT=ALT PHEN="Cardio-facio-cutaneous syndrome" GENE=BRAF]; 	9.197000,9.197000,9.197000,9.197000,9.197000,9.197000	T,,T,,T,	D,,T,,D,	D,,B,,D,	D,,D,,D,	32.00												
chr7	140453137	140453137	C	T	1.0000	5166		65343.2	BRAF	missense_variant	BRAF:NM_004333.4:missense_variant:MODERATE:exon15/18:c.1798G>A:p.Val600Met	,Serine-threonine/tyrosine-protein_kinase__1_,Protein_kinase-like_domain__1_,Protein_kinase__catalytic_domain__1_,,Serine-threonine/tyrosine-protein_kinase__1_,Protein_kinase-like_domain__1_,Protein_kinase__catalytic_domain__1_,Serine-threonine/tyrosine-protein_kinase__1_,Protein_kinase-like_domain__1_,Protein_kinase__catalytic_domain__1_		COSM33808;COSM144982;COSM219798;COSM1130;rs121913378	0.0000	0.0000	0.0000	COSM33808	164757 [BRAF (confirmed) Melanoma,malignant,somatic|Colorectal cancer,somatic|Adenocarcinoma of lung,somatic,211980|Nonsmall cell lung cancer,somatic|Cardiofaciocutaneous syndrome,115150|Noonan syndrome 7,613706|LEOPARD syndrome 3,613707];	RCV000037935.2 [likely pathogenic]; 		7.702000,7.702000,7.702000,7.702000,7.702000	T,T,T,T,D	,D,,D,D	,B,,B,P	,D,,D,D	33.00												
chr10	123279506	123279506	A	G	0.4970	1773		8501.19	FGFR2	missense_variant,sequence_feature,intron_variant,non_coding_transcript_exon_variant	FGFR2:NM_022970.3:missense_variant:MODERATE:exon7/18:c.926T>C:p.Leu309Pro,FGFR2:NM_001320654.1:missense_variant:MODERATE:exon6/17:c.242T>C:p.Leu81Pro,FGFR2:NM_023029.2:missense_variant:MODERATE:exon5/16:c.659T>C:p.Leu220Pro,FGFR2:NM_001144916.1:missense_variant:MODERATE:exon4/15:c.581T>C:p.Leu194Pro,FGFR2:NM_001144915.1:missense_variant:MODERATE:exon6/17:c.659T>C:p.Leu220Pro,FGFR2:NM_000141.4:missense_variant:MODERATE:exon7/18:c.926T>C:p.Leu309Pro,FGFR2:NM_001144917.1:missense_variant:MODERATE:exon7/16:c.926T>C:p.Leu309Pro,FGFR2:NM_001144918.1:missense_variant:MODERATE:exon5/16:c.581T>C:p.Leu194Pro,FGFR2:NM_001320658.1:missense_variant:MODERATE:exon7/18:c.926T>C:p.Leu309Pro,FGFR2:NM_001144913.1:missense_variant:MODERATE:exon6/17:c.926T>C:p.Leu309Pro,FGFR2:NM_001144919.1:missense_variant:MODERATE:exon6/17:c.659T>C:p.Leu220Pro,FGFR2:NM_022970.3:sequence_feature:LOW:exon7/18:c.926T>C:,FGFR2:NM_001144915.1:sequence_feature:LOW:exon6/17:c.659T>C:,FGFR2:NM_001144917.1:sequence_feature:LOW:exon7/16:c.926T>C:,FGFR2:NM_001144918.1:sequence_feature:LOW:exon5/16:c.581T>C:,FGFR2:NM_001144913.1:sequence_feature:LOW:exon6/17:c.926T>C:,FGFR2:NM_001144919.1:sequence_feature:LOW:exon6/17:c.659T>C:,FGFR2:NM_001144914.1:intron_variant:MODIFIER:exon5/14:c.749-4673T>C:,FGFR2:NR_073009.1:non_coding_transcript_exon_variant:MODIFIER:exon5/17:n.1228T>C:				0.0000	0.0000	0.0000		176943 [FGFR2 (confirmed) Crouzon syndrome,123500|Jackson-Weiss syndrome,123150|Beare-Stevenson cutis gyrata syndrome,123790|Pfeiffer syndrome,101600|Apert syndrome,101200|Saethre-Chotzen syndrome,101400|Craniosynostosis,nonspecific|Gastric cancer,somatic,613659|Craniofacial-skeletal-dermatologic dysplasia,101600|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis,207410|Scaphocephaly and Axenfeld-Rieger anomaly|LADD syndrome,149730|Scaphocephaly,maxillary retrusion,and mental retardation,609579|Bent bone dysplasia syndrome,614592];			9.332000	D	D,D,D,D,T,D,D,D,D,D,D,D,D	B,P,P,P,P,P,P,P,P,P	D,D,D,D,D,D,D,D,D,D,D,D	32.00												
chr17	7579472	7579472	G	C	0.5069	5601		22696.8	TP53	missense_variant	TP53:NM_000546.5:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg,TP53:NM_001126112.2:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg,TP53:NM_001126113.2:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg,TP53:NM_001126114.2:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg,TP53:NM_001126118.1:missense_variant:MODERATE:exon3/10:c.98C>G:p.Pro33Arg,TP53:NM_001276695.1:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg,TP53:NM_001276696.1:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg,TP53:NM_001276760.1:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg,TP53:NM_001276761.1:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg			COSM45985;rs1042522	0.542931	0.65996	0.66858	COSM250061, COSM3766192, COSM3766191, COSM3766190, COSM3766193	191170 [TP53 (confirmed) Colorectal cancer,114500|Li-Fraumeni syndrome,151623|Hepatocellular carcinoma,114550|Osteosarcoma,259500|Choroid plexus papilloma,260500|Nasopharyngeal carcinoma,607107|Pancreatic cancer,260350|Adrenal cortical carcinoma,202300|Breast cancer,114480|Basal cell carcinoma 7,614740|Glioma susceptibility 1,137800];	RCV000013144.4 [benign]; RCV000034639.1 [benign]; RCV000079202.7 [benign]; RCV000132165.3 [benign]; RCV000144668.1 [uncertain significance]; RCV000211157.1 [drug response]; RCV000211212.1 [drug response]; RCV000211311.1 [drug response]; RCV000211338.1 [drug response]; RCV000211395.1 [drug response]; RCV000300782.1 [benign]; 		1.015000,1.015000	T,D	T,T,T,T,T,T,T,T,T,D,T,D,D,D,D,T,T,T	B,B,B,B,B,B,P,B,B,P	D,D,D,D,D,D,D,D,D,D,D,D,D,D,D,D	7.17												
chr19	1220552	1220552	C	T	0.4974	4191	not-cod-spli	18660.1	STK11	intron_variant	STK11:NM_000455.4:intron_variant:MODIFIER:exon4/9:c.598-28C>T:				0.0000	0.0000	0.0000		602216 [STK11 (confirmed) Peutz-Jeghers syndrome,175200|Melanoma,malignant,somatic|Pancreatic cancer,260350|Testicular tumor,somatic,273300];																				
chr20	57484363	57484363	G	A	0.5003	1591	not-cod-spli	7502.89	GNAS	intron_variant	GNAS:NM_080425.3:intron_variant:MODIFIER:exon7/12:c.2515-42G>A:,GNAS:NM_016592.3:intron_variant:MODIFIER:exon7/12:c.*492-42G>A:,GNAS:NM_001309861.1:intron_variant:MODIFIER:exon7/12:c.409-42G>A:,GNAS:NM_001077490.2:intron_variant:MODIFIER:exon7/12:c.*447-42G>A:,GNAS:NM_001309840.1:intron_variant:MODIFIER:exon7/12:c.409-42G>A:,GNAS:NM_000516.5:intron_variant:MODIFIER:exon7/12:c.586-42G>A:,GNAS:NM_001077488.3:intron_variant:MODIFIER:exon7/12:c.589-42G>A:,GNAS:NM_001077489.3:intron_variant:MODIFIER:exon6/11:c.541-42G>A:,GNAS:NM_080426.3:intron_variant:MODIFIER:exon6/11:c.544-42G>A:			rs1004902	0.00858626	0.01694	0.01684		139320 [GNAS (confirmed) Pseudohypoparathyroidism Ia,103580|McCune-Albright syndrome,somatic,mosaic 174800|Pseudohypoparathyroidism Ic,612462|Osseous heteroplasia,progressive,166350|Pseudohypoparathyroidism Ib,603233|Acromegaly,somatic,102200|Pseudopseudohypoparathyroidism,612463|ACTH-independent macronodular adrenal hyperplasia,219080];																				
